Braveheart Bio, Inc. (BRVE)
17.28
-0.14
(-0.78%)
USD |
NASDAQ |
Nov 06, 10:24
Braveheart Bio Enterprise Value : 1.659B for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.659B |
| November 04, 2026 | 1.901B |
| November 03, 2026 | 2.017B |
| November 02, 2026 | 1.986B |
| October 30, 2026 | 2.028B |
| October 29, 2026 | 1.999B |
| October 28, 2026 | 2.051B |
| October 27, 2026 | 2.056B |
| October 26, 2026 | 2.060B |
| October 23, 2026 | 2.022B |
| October 22, 2026 | 2.025B |
| October 21, 2026 | 1.986B |
| October 20, 2026 | 1.916B |
| October 19, 2026 | 1.821B |
| October 16, 2026 | 1.776B |
| October 15, 2026 | 1.852B |
| October 14, 2026 | 1.833B |
| October 13, 2026 | 1.832B |
| October 12, 2026 | 1.924B |
| October 09, 2026 | 1.894B |
| October 08, 2026 | 1.810B |
| October 07, 2026 | 1.764B |
| October 06, 2026 | 1.873B |
| October 05, 2026 | 2.014B |
| October 02, 2026 | 2.006B |
| Date | Value |
|---|---|
| October 01, 2026 | 2.019B |
| September 30, 2026 | 1.910B |
| September 29, 2026 | 2.103B |
| September 28, 2026 | 1.988B |
| September 25, 2026 | 1.948B |
| September 24, 2026 | 2.195B |
| September 23, 2026 | 2.024B |
| September 22, 2026 | 2.217B |
| September 21, 2026 | 2.344B |
| September 18, 2026 | 2.720B |
| September 17, 2026 | 2.586B |
| September 16, 2026 | 2.563B |
| September 15, 2026 | 2.496B |
| September 14, 2026 | 2.524B |
| September 11, 2026 | 2.490B |
| September 10, 2026 | 2.545B |
| September 09, 2026 | 2.694B |
| September 08, 2026 | 2.739B |
| September 04, 2026 | 2.499B |
| September 03, 2026 | 2.457B |
| September 02, 2026 | 2.518B |
| September 01, 2026 | 2.457B |
| August 31, 2026 | 2.387B |
| August 28, 2026 | 2.562B |
| August 27, 2026 | 2.600B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bristol Myers Squibb Co. | 161.27B |
| Trulieve Cannabis Corp. | 2.347B |
| Journey Medical Corp. | 118.82M |
| Turn Therapeutics, Inc. | 262.14M |
| ANI Pharmaceuticals, Inc. | 1.834B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.99M |
| Total Expenses (Quarterly) | 14.99M |
| EPS Diluted (Quarterly) | -0.2066 |
| Earnings Yield | -2.14% |
| Normalized Earnings Yield | -2.135 |